Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.68%
Changement Mensuel
0.00%
Evolution sur 6 mois
-16.07%
Changement Annuel
-16.07%
Clôture Précédente
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volume
101
Marchés
Actions des Marchés US
Soins de Santé
ZVRA
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.38 M
34.42 M
34.54 M
43.43 M
54.12 M
—
Valuation ratios
Enterprise value
—
—
—
253.55 M
417.54 M
1.72 B
Price to earnings ratio
—
—
—
5.26
3.66
15.31
Price to sales ratio
—
—
—
8.82
16.34
39.01
Price to cash flow ratio
—
—
—
7.22
5.54
40.12
Price to book ratio
—
—
—
3.91
9.72
14.94
Enterprise value to EBITDA ratio
—
—
—
-5.12
-4.81
15.41
Profitability ratios
Return on assets %
1.14
0.06
0.36
0.27
0.59
0.51
Return on equity %
0.19
0.07
0.48
0.74
2.66
1.62
Return on invested capital %
551.89
270.19
707.94
249.94
249.48
426.9
Gross margin %
100
100
96.72
89.28
42.18
308.33
Operating margin %
42.21
26.98
406.44
180.63
368.47
443.72
EBITDA margin %
—
—
-42.2
-180.26
-367.86
131.87
Net margin %
96.03
29.86
397.24
167.69
446.85
600.79
Liquidity ratios
Quick ratio
—
—
—
1.05
2.47
21.45
Current ratio
1.11
27.2
7.93
1.18
2.53
22.02
Inventory turnover
—
—
—
—
2.31
8.41
Asset turnover
1.22
0.4
0.08
0.19
0.13
0.4
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
6.07
0
0.11
0.03
0.33
1.15
Long term debt to total equity ratio
1.02
0
0.15
0.08
1.5
3.94
Per share metrics
Operating cash flow per share
—
0.35
0.54
0.95
1.51
0.48
EBIT per share
—
—
-0.16
-1.42
-2.02
0.85
EBITDA per share
—
—
-0.13
-1.4
-1.88
0.95
Total debt per share
—
—
—
—
—
—
Cash per share
—
3.77
2.4
1.91
1.5
9.82
Net current asset value per share
—
3.87
2.7
2.45
1.86
11.41
Tangible book value per share
—
4.27
2.49
-0.34
-0.74
2.74
Working capital per share
—
3.72
2.36
0.37
1.12
9.2
Book value per share
—
4.27
2.49
1.75
0.86
6.08
Nouvelles
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, président de Zevra Therapeutics, vend des actions pour 125k $
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Le directeur médical de Zevra Therapeutics vend des actions pour 40.000€
Joshua Schafer, CCO de Zevra, vend des actions ZVRA pour 29.800€
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
Le PDG de Zevra Therapeutics, McFarlane, vend des actions pour 853.425€
Zevra Therapeutics CEO McFarlane sells $853k in shares
Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)